NDC 51662-1334

PROCAINAMIDE HCI

Procainamide Hci

PROCAINAMIDE HCI is a Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Procainamide Hydrochloride.

Product ID51662-1334_8192d79d-da2c-2532-e053-2991aa0ae8ad
NDC51662-1334
Product TypeHuman Prescription Drug
Proprietary NamePROCAINAMIDE HCI
Generic NameProcainamide Hci
Dosage FormInjection, Solution
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS
Marketing Start Date2019-02-10
Marketing CategoryANDA / ANDA
Application NumberANDA089069
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NamePROCAINAMIDE HYDROCHLORIDE
Active Ingredient Strength100 mg/mL
Pharm ClassesAntiarrhythmic [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 51662-1334-1

1 VIAL, MULTI-DOSE in 1 CARTON (51662-1334-1) > 10 mL in 1 VIAL, MULTI-DOSE
Marketing Start Date2019-02-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51662-1334-1 [51662133401]

PROCAINAMIDE HCI INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA089069
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-02-10

Drug Details

Active Ingredients

IngredientStrength
PROCAINAMIDE HYDROCHLORIDE100 mg/mL

OpenFDA Data

SPL SET ID:8192d79d-da2b-2532-e053-2991aa0ae8ad
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 857886
  • Pharmacological Class

    • Antiarrhythmic [EPC]

    NDC Crossover Matching brand name "PROCAINAMIDE HCI" or generic name "Procainamide Hci"

    NDCBrand NameGeneric Name
    51662-1334PROCAINAMIDE HCIPROCAINAMIDE HCI
    51662-1392PROCAINAMIDE HCIPROCAINAMIDE HCI

    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.